Houston: Dr. Samba Reddy, a faculty member of the Texas A&M University College of Medicine, received a promotion to Professor, the highest academic rank given to exemplify international recognition in medical research and teaching. At the age of 42 years, he achieved the rare distinction of being one of the youngest full professors in US Medical schools. Winning this professorship is the dream of every faculty member. Only meritorious faculty achieves such a title so early in their career.
Dr. Reddy achieved the coveted Professor title for his outstanding contribution to medical and pharmaceutical research over the last two decades. He was recommended for this prestigious title by a panel of highly eminent medical professors in the United States.
Dr. Reddy is a native of Warangal. Despite coming from a humble rural background, he excelled in education, scientific research, profession and service sectors, and became a highly regarded medical professor and pharmaceutical scientist in the USA.
Dr. Reddy is a pharmacologist working in the area of new drug development for neurological diseases. He is developing new medications for epilepsy, migraine, status epilepticus and brain injury. He is involved in teaching medical and graduate courses, and is directing a U.S. federal NIH-funded research program at Texas A&M University. He is a board-certified pharmacist, delegate member of the U.S. Pharmacopeia, a Chartered member of the NIH study section CNNT, Editor-in-Chief of the International Journal of Pharmaceutical Sciences and Nanotechnology, and Review Editor of the Aging Neuroscience journal.
Dr. Reddy has published over 100 research papers, written 6 major books, and presented over 150 seminars and lectures worldwide – a commendable accomplishment at such young age. He helped develop a new drug ganaxolone and solved several biomedical problems through his dedicated research work.
He has received several awards and honors for his exceptional services including the IDMA Award, Malhotra Award, Prous Award, Uvnas Award, NIH-FARE Award, and Sigma Xi Award. Recently, he was honored with the 2012 NATA Award of Research Excellence in Drug Discovery for his pioneering work discovering many novel treatments that have a profound impact on reducing the burden of brain illness in millions of patients worldwide.
He is actively involved in community and social service projects both in the US and India. He conducts health camps, charity events and educational programs for the needy.
